miraDry treatment prices vary by market far more than the device cost does: the same service books at roughly $2,150 in one US clinic, around CAD 2,500 in a Canadian clinic, near €1,700 in a French practice, and from about ¥200,000 upward across Tokyo clinic pages depending on plan and campaign. For a clinic planning the service, that spread is useful only as context. Your price should come from your own case cost — bioTip, operator time, room, and acquisition — not from the highest sticker in your city. This guide translates dated market observations into a margin model any clinic can rebuild from its own numbers.

Treatment-plan and candidate questions belong to your medical director with current labeling for your market. What this guide covers is the business arithmetic around the service.

What treatment pricing looks like by market

The observations below are dated clinic price pages, not a price list. They show how the same service is packaged differently by market — some clinics price one session as the complete treatment, others build plans of one or two sessions with supplementary pricing:

Read the table with three rules. First, published prices are not your prices — they include each clinic’s market position, rent, and acquisition cost. Second, package structure changes the comparison: “one-time treatment” and “two-session plan” are different products even at the same nominal number. Third, currency conversions are indicative; use transaction-date rates when comparing.

Cost structure per case

Build the case cost from four lines, all from written quotes and your own operations:

• Consumable: the single-use bioTip per treatment session. Dated marketplace context in the companion bioTip guide shows MD4500-BT stock listed around €345.95 at one EU reseller (out of stock at retrieval); your delivered price per usable tip from an authorized channel is the number that belongs in this model.
• Operator time: miraDry sessions are procedure-time events — Tokyo clinics describe roughly one hour of total treatment time — so price the nurse or therapist hour at your local rate.
• Room and overhead: allocate treatment-room cost, sterilization or housekeeping time, and utilities per session.
• Acquisition: the marketing cost per booked treatment, including consultation no-shows that never convert.

Write each line down before setting a price. Clinics that skip the consumable line discover after launch that the per-case margin is thinner than the brochure suggested.

Two less obvious costs belong in the worksheet too. The consultation is a real cost: a candidate who books a consultation but does not proceed still consumed a room and a clinician’s hour, so divide your consultation cost by the conversion rate before pricing the treatment. And the retreatment policy is a cost line disguised as a marketing decision — if your published policy includes a free or discounted second session, that second session’s variable cost belongs to every first sale’s margin. Price the policy before you publish it, not after patients start asking.

Pricing models and packages

Three package shapes appear across markets, and each changes the arithmetic:

• Single-session complete treatment: one price, one session, as the US observation shows; simplest to communicate, hardest to add retreatment revenue.
• Base plus supplementary: a lower base with add-on pricing, as the Canadian example shows with a separate retreatment line; useful for honest upsell framing.
• Campaign pricing: time-limited offers common in Tokyo; effective for demand spikes but should be modeled at campaign volume, not list volume.

Whichever shape you choose, publish the plan boundaries: what one treatment includes, when a second session is priced separately, and what your retreatment policy is. Vague plans convert poorly and create the exact price complaints that sink a new service line.

Revenue planning with assumptions

Use a transparent model with labeled assumptions. Per-case contribution:

Case price − (bioTip delivered cost + operator hour + room allocation + acquisition cost) = per-case contribution.

Then multiply by capacity: treatment slots per week × average utilization × weeks per year. Example with every input labeled as an assumption: assume a $2,000 case price, $400 total variable cost, two treatment slots per week, 70% utilization, and 48 operating weeks. That yields about 67 cases and roughly $107,000 of annual contribution before fixed marketing and overhead. If your bioTip cost, slot count, or utilization differs, rebuild the arithmetic — the model is the deliverable, not the example.

Two modeling cautions: campaign periods should be modeled at campaign utilization separately, and retreatment revenue should only appear if your published plan actually prices it.

Add a ramp assumption so the model stays honest in the first quarter. New service lines rarely open at target utilization — realistic planning assumes 40–60% of target slots for the first eight to twelve weeks while the treatment page ranks, staff build confidence, and referrals arrive. Run the contribution model at the ramp rate and at target rate side by side, and set your launch decision on the ramp number. If the service still clears its fixed marketing and overhead at ramp utilization, the launch is funded by the model; if it only works at full utilization, the launch depends on a schedule you have not yet proven.

Compliance and screening cautions

miraDry is a medical device with approved labeling that differs by market, and clinics must operate within current local labeling and registration. Candidate screening — who is suitable and what information they receive — is a clinical and regulatory question for your medical director, not a marketing decision. Do not publish outcome promises from another market’s brochure, and confirm your jurisdiction’s rules on who may perform the procedure and what documentation must be kept. A pricing page cannot fix a compliance gap; it can only make one more visible.

Next steps for adding the service

Before launch, close four lines: written bioTip pricing with lead time, a dated local price study (use the table above as a starting template), a per-case cost model with your own numbers, and a compliance review of labeling, registration, and operator requirements. Current miraDry system documentation and inventory anchors the device side, and the bioTip supply guide covers the consumable channel. Set the price from your model, publish the plan boundaries, and let the first quarter’s utilization tell you whether the assumptions were right — the market stickers are context, and your worksheet is the business.

Put dates on the plan while you are at it: bioTip order placed before the first consultation is booked, price study refreshed in the week before launch, and a 90-day review of actual utilization against the model written into the calendar now. A launch plan without review dates is a hope with a price tag; the 90-day review is what turns the assumption labels in this guide into a decision record for quarter two.